Skip to main content
SpringerLink
Log in

Leberzirrhose

  • Chapter
Medikamentöse Therapie in der Gastroenterologie

Part of the book series: Kliniktaschenbücher ((KTB))

  • 37 Accesses

Zusammenfassung

Die Leberzirrhose ist gekennzeichnet durch eine abnorme Vermehrung von Bindegewebe, die die Läppchenarchitektur zerstört. Der zur Bindegewebsvermehrung führende Pathomechanismus ist unbekannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Kershenobich D, Vargus F, Gercia-Tsao G et al. (1988) Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 318: 1709–1713

    Article  PubMed  CAS  Google Scholar 

  2. Junge U (1986) Die medikamentöse Therapie der Ösophagusvarizenblutung. Dtsch Med Wochenschr 111: 627–630

    Article  PubMed  CAS  Google Scholar 

  3. Fleig WE (1988) Pharmacological methods for the prevention of first and recurrent bleeding from esophagogastric varices. Z Gastroenterol 26 [Suppl. 2]: 40–48

    Google Scholar 

  4. Walker S (1988) Behandlung der Ösophagusvarizenblutung mit vasoaktiven Substanzen. Dtsch Med Wochenschr 113: 26–31

    Article  PubMed  CAS  Google Scholar 

  5. Bosch J (1985) Effect of pharmacological agents on portal hypertension. Clin Gastroenterol 14: 169–184

    PubMed  CAS  Google Scholar 

  6. Staritz M, Poralla T, Meyer zum Büschenfelde KH (1985) Intravascular oesophageal variceal pressure assessed by endoscopic fine needle puncture under basal conditions, Vasalva’s manoevre and after glycyltrinitrate application. Gut 26: 525–527

    Article  PubMed  CAS  Google Scholar 

  7. Lebrec D, Poynard T, Hillon R, Benhamou JP (1981) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 305: 1371–1374

    Article  PubMed  CAS  Google Scholar 

  8. Gerbes AL (1987) Neuere Aspekte in der Diagnose und Therapie des Aszites. Z Gastroenterol 25: 677–682

    PubMed  CAS  Google Scholar 

  9. Gross P, Ketteier M, Sieg A (1987) Störungen des Wasserhaushaltes bei Leberzirrhose. Internist 28: 443–447

    PubMed  CAS  Google Scholar 

  10. Schölmerich J (1987) Diagnostik und Therapie des Aszites. Internist 28: 448–458

    PubMed  Google Scholar 

  11. Ring-Larsen H, Henriksen JH, Wilken C et al. (1986) Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J 292: 1351–1353

    Article  CAS  Google Scholar 

  12. Gauthier A, Levy VG, Quinton A et al. (1986) Salt or no salt in the treatment of cirrhotic ascites: A randomised Study. Gut 27: 705–709

    Article  PubMed  CAS  Google Scholar 

  13. Mirouze D, Zipser RD, Reynolds TB (1983) Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology 3: 50–55

    Article  PubMed  CAS  Google Scholar 

  14. Gines P, Arroyo V, Quintere E et al. (1987) Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 93: 234–241

    PubMed  CAS  Google Scholar 

  15. Perez-Ayuso RM, Arroyo V, Planas R et al. (1983) Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 84: 961–968

    PubMed  CAS  Google Scholar 

  16. Schölmerich J, Volk BA, Köttgen E et al. (1985) Ascites -neue Aspekte zur Pathophysiologie, Diagnostik und Therapie. Dtsch Med Wochenschr 110: 512–518

    Article  PubMed  Google Scholar 

  17. Gerok W (1985) Metabolische Grundlagen der hepatischen Enzephalopathie. Internist 26: 377–387

    PubMed  CAS  Google Scholar 

  18. Swart GR, Frenkel M, Van den Berg J (1981) Minimum protein requirements in advanced liver disease. In: Walser M, Williamson JR (eds) Metabolism and clinical implications of branched-chain amino-and ketoacids. Elsevier, New York, pp 427–432

    Google Scholar 

  19. Weber FL (1984) Hepatic encephalopathy. Gastroenterology 84: 197–237

    Google Scholar 

  20. Bircher J, Müller J, Guggenheim P et al. (1966) Treatment of chronic portal systemic encephalopathy with lactulose. Lancet I: 890–893

    Google Scholar 

  21. Weber FL, Fresard KM, Lally BR (1982) Effects of lactulose and neomycin on liver metabolism in cirrhotic subjects. Gastroenterology 82: 213–217

    PubMed  Google Scholar 

  22. Conn HO, Leevy CM, Vlahcevic ZR et al. (1977) Comparison of lactulose and neomycin in the treatment of chronic portosystemic encephalopathy. A double blind controlled trial. Gastroenterology 72: 573–583

    CAS  Google Scholar 

  23. Morgan MH, Hawlly KE, Stambeck D (1987) Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy: A double-blind, randomized, crossover study. J Hepatol 4: 236–245

    Article  PubMed  CAS  Google Scholar 

  24. Morgan MH, Read AE, Speller DCE (1982) Treatment of hepatic encephalopathy with metronidazol. Gut 23: 1–7

    Article  PubMed  CAS  Google Scholar 

  25. Gerok W (1986) Therapie mit differenzierten Aminosäuregemischen bei hepatischer Enzephalopathie. Arzneimitteltherapie 4: 72–77

    Google Scholar 

  26. Egberts EH (1987) Therapie der hepatischen Enzephalopathie. Leber Magen Darm 7: 244–273

    Google Scholar 

  27. Reding P, Duchabeau J, Betaille C (1984) Oral Zinc supplement improves hepatic encephalopathy. Lancet II: 493–495

    Google Scholar 

  28. Editorial (1980) Hepatorenal syndrome or hepatic nephropathy. Lancet 1:801–803

    Google Scholar 

  29. Köhler H, Meyer zum Büschenfelde KH (1988) Funktionelle Beziehung zwischen Leber und Niere. Dtsch Med Wochenschr 113: 1524–1527

    Article  PubMed  Google Scholar 

  30. Wilkinson SP, Weston MJ et al. (1977) Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8: 287–292

    PubMed  CAS  Google Scholar 

  31. Kramer HJ (1988) Therapie des hepatorenalen Syndroms. Dtsch Med Wochenschr 133: 561–564

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik, Robert-Koch-Straße 40, 3400, Göttingen, Deutschland

    Prof. Dr. med. Ulrich R. Fölsch

  2. Medizinische Klinik, Städtische Krankenanstalten Rosenhöhe, 4800, Bielefeld 14, Deutschland

    Prof. Dr. med. Ulrich Junge

Authors
  1. Prof. Dr. med. Ulrich R. Fölsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Ulrich Junge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fölsch, U.R., Junge, U. (1990). Leberzirrhose. In: Medikamentöse Therapie in der Gastroenterologie. Kliniktaschenbücher. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87466-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87466-6_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51886-0

  • Online ISBN: 978-3-642-87466-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation